Plasma natriuretic peptide concentrations as a predictor for successful catheter ablation in patients with drug-refractory atrial fibrillation

Circulation Journal

Volumn 71, Issue 3, 2007, Pages 313-320

  Kurosaki, Kenji ^a   Tada, Hiroshi ^a,b   Hashimoto, Tohru ^a   Ito, Sachiko ^a   Miyaji, Kohei ^a   Naito, Shigeto ^a   Oshima, Shigeru ^a   Taniguchi, Koichi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b GUNMA PREFECTURAL CARDIOVASCULAR CENTER   (Japan)

Author keywords

Atrial fibrillation; Atrial natriuretic peptide; Brain natriuretic peptide; Catheter ablation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CIBENZOLINE; DISOPYRAMIDE; FLECAINIDE; PILSICAINIDE; PIRMENOL; PROCAINAMIDE; SOTALOL;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CATHETER ABLATION; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

AGED; ATRIAL FIBRILLATION; ATRIAL NATRIURETIC FACTOR; CATHETER ABLATION; DRUG RESISTANCE; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 33947124104     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.313     Document Type: Article

References (26)

1. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321-328.
2. van den Berg MP, van Gelder IC, van Veldhuisen DJ. Depletion of atrial natriuretic peptide during longstanding atrial fibrillation. Europace 2004; 6: 433-437.
3. McKie PM, Burnett JC Jr. B-type natriuretic peptide as a biomarker beyond heart failure: Speculations and opportunities. Mayo Clin Proc 2005; 80: 1029-1036.
4. Roy D, Paillard F, Cassidy D, Bourassa MG, Gutkowska J, Genest J, et al. Atrial natriuretic factor during atrial fibrillation and supraventncular tachycardia. J Am Coll Cardiol 1987; 9: 509-514.
5. Inoue S, Murakami Y, Sano K, Katoh H, Shimada T. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 2000; 6: 92-96.
6. Lee SH, Jung JH, Choi SH, Lee N, Park WJ, Oh DJ, et al. Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation. Circ J 2006; 70: 100-104.
7. Wozakowska-Kaplon B, Opolski G. Atrial natriuretic peptide level after cardioversion of chronic atrial fibrillation. Int J Cardiol 2002; 83: 159-165.
8. Silvet H, Young-Xu Y, Walleigh D, Ravid S. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol 2003; 92: 1124-1127.
9. Wozakowska-Kaplon B. Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol 2004; 93: 1555-1558.
10. Thomas MD, Kalra PR, Jones A, Struthers AD, More RS. Time course for recovery of atrial mechanical and endocrine function post DC cardioversion for persistent atrial fibrillation. Int J Cardiol 2005; 102: 487-491.
11. Oral H, Scharf C, Chugh A, Hall B, Cheung P, Good E, et al. Catheter ablation for paroxysmal atrial fibrillation: Segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 2003; 108: 2355-2360.
12. Kumagai K, Ogawa M, Noguchi H, Nakashima H, Zhang B, Miura S, et al. Comparison of 2 mapping strategies for pulmonary vein isolation. Circ J 2005; 69: 1496-1502.
13. Tada H, Naito S, Kurosaki K, Ueda M, Ito S, Shinbo G, et al. Segmental pulmonary vein isolation for paroxysmal atrial fibrillation improves quality of life and clinical outcomes. Circ J 2003; 67: 861-865.
14. Tada H, Kurosaki K, Ito S, Naito S, Yamada M, Miyaji K, et al. Left atrial and pulmonary vein ostial ablation as a new treatment for curing persistent atrial fibrillation. Circ J 2005; 69: 1057-1063.
15. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976; 37: 7-11.
16. Tsuji T, Imagawa K, Masuda H, Haraikawa M, Shibata K, Kono M, et al. Stabilization of human natriuretic peptide in blood samples. Clin Chem 1994; 40: 672-673.
17. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96: 509-516.
18. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350: 655-663.
19. Berglund H, Boukter S, Theodorsson E, Vallin H, Edhag O. Raised plasma concentrations of atrial natriuretic peptide are independent of left atrial dimensions in patients with chronic atrial fibrillation. Br Heart J 1990; 64: 9-13.
20. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: Impact of age and gender. J Am Coll Cardiol 2002; 40: 976-982.
21. Watanabe M, Murakami M, Furukawa H, Nakahara H, Tanaka H, Sunamori M. Decreased plasma brain natriuretic peptide levels after a successful maze procedure. J Heart Valve Dis 2003; 12: 287-291.
22. Wazni OM, Martin DO, Marrouche NF, Latif AA, Ziada K, Shaaraoui M, et al. Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 2004; 110: 124-127.
23. Mabuchi N, Tsutamoto T, Maeda K, Kinoshita M. Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure. Jpn Circ J 2000; 64: 765-771.
24. Conen D, Pfisterer M, Martina B. Substantial intraindividual variability of BNP concentrations in patients with hypertension. J Hum Hypertens 2006; 20: 387-391.
25. Hindricks G, Piorkowski C, Tanner H, Kobza R, Gerds-Li JH, Carbucicchio C, et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: Relevance of asymptomatic arrhythmia recurrence. Circulation 2005; 112: 307-313.
26. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: Comparison with Doppler velocity recordings. Circulation 2002; 105: 595-601.